1-3 of 3
Mark G Manfredi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pre-Clinical Antitumor activity of MLN4924, An Inhibitor of NEDD8-Activating Enzyme (NAE), in a Novel Primary Human DLBCL Xenograft Model.

Tary Traore, James J. Garnsey, Erik Koenig, Allison J Berger, Mark G Manfredi, PhD, Lilli Petruzzelli, MD, PhD, Peter G. Smith, PhD
Journal: Blood
Blood (2009) 114 (22): 927.
https://doi.org/10.1182/blood.V114.22.927.927
Published: 2009
Journal Articles

In-Vitro and in-Vivo Evaluation of the Orally Active Proteasome Inhibitor MLN9708 in Hematological Models of Human Cancer.

Erik Kupperman, Edmund Lee, Yueying Cao, Bret Bannerman, Michael Fitzgerald, Allison J Berger, Jie Yu, Julie Zhang, Paul Hales, Frank Bruzzese, Jane Liu, Jonathan Blank, Khristofer Garcia, Christopher Tsu, Larry Dick, Paul Fleming, Li Yu, Mark G Manfredi, Mark Rolfe, Joseph Bolen
Journal: Blood
Blood (2009) 114 (22): 2709.
https://doi.org/10.1182/blood.V114.22.2709.2709
Published: 2009
Journal Articles

Anti-Tumor Activity of the Aurora a Inhibitor MLN8237 in Diffuse Large B-Cell Lymphoma Preclinical Models.

Jessica J Huck, BA, Mengkun Zhang, MD, Marc L Hyer, PhD, Mark G Manfredi, PhD
Journal: Blood
Blood (2008) 112 (11): 1592.
https://doi.org/10.1182/blood.V112.11.1592.1592
Published: 2008